The First Innovation in Treatment of Low Testosterone in Men Since 1930th
Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment of low testosterone in men in over 80 years.
Low testoterone (T) in men [hypogonadism] is a condition in which the testicular cells do not produce enough of the hormone T that is essential in masculine growth and pubertal development. As males age, there is a natural decline of T levels after age 30 and continues (about 1% drop per year) throughout their life. The decrease of T levels is often accompanied by erectile dysfunction, decreased muscle mass, osteoporosis, fatigue and mental fogginess, decreased libido and it may predispose men to obesity, insulin resistance and hypertension. There are many other potential causes of low testosterone other than the natural decline, including: testicular trauma, chemotherapy treatments, kidney failure, HIV, opioid or alcohol abuse, obesity, diabetes type 2, Klinefelter syndrome (a genetic condition in which a male is born with an extra copy of the X chromosome), head injury etc.
Topics: HealthTech
